Neurelis Inc Company Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What is the competitive landscape for NEURELIS INC, and when can generic versions of NEURELIS INC drugs launch?
NEURELIS INC has one approved drug.
There are five US patents protecting NEURELIS INC drugs.
There are eighty patent family members on NEURELIS INC drugs in twenty-six countries.
Summary for Neurelis Inc
| International Patents: | 80 |
| US Patents: | 5 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Neurelis Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Neurelis Inc | VALTOCO | diazepam | SPRAY;NASAL | 211635-003 | Jan 10, 2020 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | |||||
| Neurelis Inc | VALTOCO | diazepam | SPRAY;NASAL | 211635-003 | Jan 10, 2020 | RX | Yes | Yes | 8,927,497 | See Plans and Pricing | Y | See Plans and Pricing | |||
| Neurelis Inc | VALTOCO | diazepam | SPRAY;NASAL | 211635-003 | Jan 10, 2020 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | |||||
| Neurelis Inc | VALTOCO | diazepam | SPRAY;NASAL | 211635-002 | Jan 10, 2020 | RX | Yes | No | 8,895,546 | See Plans and Pricing | Y | See Plans and Pricing | |||
| Neurelis Inc | VALTOCO | diazepam | SPRAY;NASAL | 211635-002 | Jan 10, 2020 | RX | Yes | No | 9,642,913 | See Plans and Pricing | Y | See Plans and Pricing | |||
| Neurelis Inc | VALTOCO | diazepam | SPRAY;NASAL | 211635-001 | Jan 10, 2020 | RX | Yes | No | 8,927,497 | See Plans and Pricing | Y | See Plans and Pricing | |||
| Neurelis Inc | VALTOCO | diazepam | SPRAY;NASAL | 211635-002 | Jan 10, 2020 | RX | Yes | No | 11,241,414 | See Plans and Pricing | Y | See Plans and Pricing | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Neurelis Inc Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Serbia | 63866 | See Plans and Pricing |
| European Patent Office | 3082817 | See Plans and Pricing |
| Spain | 2917973 | See Plans and Pricing |
| Portugal | 3415139 | See Plans and Pricing |
| Spain | 2791775 | See Plans and Pricing |
| Denmark | 2381773 | See Plans and Pricing |
| Russian Federation | 2011130526 | See Plans and Pricing |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
